Typicality: | 0.376 |
Saliency: | 0.295 |
at ibex preclinical research inc. | 2 | location |
protocol → be approved by → the iacuc | 10 |
protocol → be approved by → iacuc | 5 |
negative | neutral | positive |
0.101 | 0.613 | 0.286 |
Raw frequency | 15 |
Normalized frequency | 0.295 |
Modifier score | 0.500 |
Perplexity | 48.659 |